AS Latvijas Juras medicinas centrs (UOM.MU)
EUR 6.0
(0.0%)
EUR 6.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 9.83 Million EUR | 1.41% |
| 2022 | 9.7 Million EUR | 3.6% |
| 2021 | 9.36 Million EUR | 32.24% |
| 2020 | 7.08 Million EUR | -2.62% |
| 2019 | 7.27 Million EUR | 8.98% |
| 2018 | 6.67 Million EUR | 5.47% |
| 2017 | 6.32 Million EUR | 4.72% |
| 2016 | 6.04 Million EUR | 4.37% |
| 2015 | 5.78 Million EUR | -0.96% |
| 2014 | 5.84 Million EUR | 14.68% |
| 2013 | 5.09 Million EUR | -5.69% |
| 2012 | 5.4 Million EUR | 7.87% |
| 2011 | 5 Million EUR | 6.08% |
| 2010 | 4.72 Million EUR | -27.27% |
| 2009 | 6.49 Million EUR | -22.59% |
| 2008 | 8.38 Million EUR | 12.42% |
| 2007 | 7.45 Million EUR | 31.64% |
| 2006 | 5.66 Million EUR | 3.52% |
| 2005 | 5.47 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.53 Million EUR | -2.37% |
| 2024 Q2 | 2.46 Million EUR | -2.83% |
| 2023 Q4 | 2.6 Million EUR | -0.21% |
| 2023 Q1 | 2.25 Million EUR | -5.1% |
| 2023 FY | 9.83 Million EUR | 1.41% |
| 2023 Q3 | 2.6 Million EUR | 10.01% |
| 2023 Q2 | 2.36 Million EUR | 4.92% |
| 2022 Q1 | 2.69 Million EUR | 9.75% |
| 2022 Q3 | 2.13 Million EUR | -14.28% |
| 2022 Q2 | 2.49 Million EUR | -7.44% |
| 2022 Q4 | 2.38 Million EUR | 11.42% |
| 2022 FY | 9.7 Million EUR | 3.6% |
| 2021 Q3 | 2.28 Million EUR | -5.35% |
| 2021 Q2 | 2.41 Million EUR | 9.65% |
| 2021 Q4 | 2.45 Million EUR | 7.21% |
| 2021 FY | 9.36 Million EUR | 32.24% |
| 2021 Q1 | 2.2 Million EUR | 20.57% |
| 2020 FY | 7.08 Million EUR | -2.62% |
| 2020 Q1 | 1.82 Million EUR | -3.6% |
| 2020 Q2 | 1.41 Million EUR | -22.33% |
| 2020 Q3 | 2.01 Million EUR | 42.55% |
| 2020 Q4 | 1.82 Million EUR | -9.31% |
| 2019 Q4 | 1.88 Million EUR | 3.61% |
| 2019 Q1 | 1.78 Million EUR | -2.53% |
| 2019 Q3 | 1.82 Million EUR | 3.04% |
| 2019 FY | 7.27 Million EUR | 8.98% |
| 2019 Q2 | 1.76 Million EUR | -1.08% |
| 2018 Q1 | 1.67 Million EUR | 0.42% |
| 2018 FY | 6.67 Million EUR | 5.47% |
| 2018 Q4 | 1.83 Million EUR | 23.9% |
| 2018 Q3 | 1.48 Million EUR | -12.09% |
| 2018 Q2 | 1.68 Million EUR | 0.88% |
| 2017 Q2 | 1.53 Million EUR | -3.69% |
| 2017 Q1 | 1.59 Million EUR | -0.38% |
| 2017 FY | 6.32 Million EUR | 4.72% |
| 2017 Q3 | 1.53 Million EUR | -0.24% |
| 2017 Q4 | 1.66 Million EUR | 8.57% |
| 2016 Q1 | 1.49 Million EUR | -1.36% |
| 2016 Q4 | 1.6 Million EUR | 9.56% |
| 2016 FY | 6.04 Million EUR | 4.37% |
| 2016 Q3 | 1.46 Million EUR | -1.38% |
| 2016 Q2 | 1.48 Million EUR | -1.11% |
| 2015 Q4 | 1.51 Million EUR | 11.49% |
| 2015 Q3 | 1.36 Million EUR | -5.53% |
| 2015 Q1 | 1.46 Million EUR | -19.39% |
| 2015 Q2 | 1.44 Million EUR | -1.62% |
| 2015 FY | 5.78 Million EUR | -0.96% |
| 2014 Q4 | 1.81 Million EUR | 44.58% |
| 2014 Q1 | 1.41 Million EUR | 1.36% |
| 2014 Q3 | 1.25 Million EUR | -6.76% |
| 2014 FY | 5.84 Million EUR | 14.68% |
| 2014 Q2 | 1.34 Million EUR | -5.03% |
| 2013 Q4 | 1.4 Million EUR | 16.98% |
| 2013 FY | 5.09 Million EUR | -5.69% |
| 2013 Q3 | 1.19 Million EUR | -3.83% |
| 2013 Q1 | 1.25 Million EUR | -24.09% |
| 2013 Q2 | 1.24 Million EUR | -0.54% |
| 2012 Q4 | 1.64 Million EUR | 41.48% |
| 2012 FY | 5.4 Million EUR | 7.87% |
| 2012 Q1 | 1.33 Million EUR | -1.69% |
| 2012 Q2 | 1.24 Million EUR | -6.81% |
| 2012 Q3 | 1.16 Million EUR | -6.61% |
| 2011 Q2 | 1.24 Million EUR | -0.16% |
| 2011 FY | 5 Million EUR | 6.08% |
| 2011 Q1 | 1.24 Million EUR | -2.36% |
| 2011 Q4 | 1.36 Million EUR | 18.08% |
| 2011 Q3 | 1.15 Million EUR | -7.32% |
| 2010 Q4 | 1.27 Million EUR | 2.93% |
| 2010 Q1 | 1.13 Million EUR | -1.88% |
| 2010 FY | 4.72 Million EUR | -27.27% |
| 2010 Q2 | 1.06 Million EUR | -6.55% |
| 2010 Q3 | 1.24 Million EUR | 16.57% |
| 2009 Q2 | 2.21 Million EUR | 2.89% |
| 2009 Q3 | 960.67 Thousand EUR | -56.65% |
| 2009 FY | 6.49 Million EUR | -22.59% |
| 2009 Q4 | 1.16 Million EUR | 20.85% |
| 2009 Q1 | 2.15 Million EUR | 0.0% |
| 2008 FY | 8.38 Million EUR | 12.42% |
| 2007 FY | 7.45 Million EUR | 31.64% |
| 2006 FY | 5.66 Million EUR | 3.52% |
| 2005 FY | 5.47 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|